Top October 24, 2026 at 12:25 PM

Moderna’s cancer vaccine is ‘likely’ to get approved. Skeptics question if it will be the best option.

MarketWatch Top Stories

The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed.

Excerpt from MarketWatch Top Stories.

In the season premiere of "48 Hours Post Mortem," correspondents Anne-Marie Green and Peter Van Sant discuss the brillia…

“We worked out a monthly budget of $1,500 for her share of rent, utilities and food, including groceries and meals on ca…

Generation Z drinks less than Boomers, Millennials and Gen X. The trend began with the Covid-19 pandemic, which delayed …

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play